LIVN LivaNova PLC
Healthcare$73.83+0.26%ClosedMarket Cap: $4.06B
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
3.33
P/S
2.83
EV/EBITDA
16.53
DCF Value
$-14.20
FCF Yield
4.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
67.6%
Operating Margin
14.2%
Net Margin
7.5%
ROE
9.1%
ROA
4.3%
ROIC
10.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $362.3M | 67.6% | $52.2M | $22.3M | $— | — |
| Q4 null | $360.9M | 66.4% | $42.6M | $30.9M | $— | — |
| FY null | $1.39B | 67.7% | $199.4M | $-242.5M | $— | — |
| Q3 null | $357.8M | 68.4% | $54.0M | $26.8M | $— | — |
| Q2 null | $352.5M | 67.8% | $54.2M | $27.2M | $— | — |
| Q1 null | $316.9M | 69.7% | $48.6M | $-327.3M | $— | — |
| Q4 null | $321.8M | 68.2% | $37.0M | $55.9M | $— | — |
| FY null | $1.25B | 69.5% | $129.1M | $63.2M | $— | — |
| Q3 null | $318.1M | 70.8% | $35.6M | $33.0M | $— | — |
| Q2 null | $318.6M | 67.4% | $40.2M | $16.3M | $— | — |
| Q1 null | $294.9M | 70.3% | $16.2M | $-41.9M | $— | — |
| Q4 2023 | $310.1M | 61.3% | $-88.0M | $16.3M | $0.30 | — |